Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 25, 2025 Tarsus Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is ...
manilatimes10d
Tarsus Reports Strong Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Achievements
XDEMVY (lotilaner ophthalmic solution, 0.25%) is FDA approved in the United States for the treatment of Demodex blepharitis.
How to use baby shampoo to calm stubborn or uncomfortable styes at home
Treating a stye requires a light-handed approach. We spoke with experts about how to do so at home along with tips and ...
People16d
Woman Gets Fat Injections in Eyelid to Resolve 'Facial Asymmetry' — and Five Stuck Contact Lenses Pop Out
Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons A woman’s swollen eye turned out to ... underneath her upper eyelid. An “otherwise healthy ...
Life Science Leader22d
Where Are They Now? Tarsus Pharmaceuticals
Then: In the May 2023 issue of Life Science Leader, Bobak Azamian, MD, Ph.D., cofounder and CEO of Tarsus Pharmaceuticals, talked about the company’s formation in 2016, and the decision to focus on ...